Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer

The detection of plasma cell–free tumor DNA (ctDNA) is prognostic in colorectal cancer (CRC) and has potential for early prediction of disease recurrence. In clinical routine, ctDNA-based diagnostics are limited by the low concentration of ctDNA and error rates of standard next-generation sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Stasik, Sebastian, Mende, Marika, Schuster, Caroline, Mahler, Sandra, Aust, Daniela, Tannapfel, Andrea, Reinacher-Schick, Anke, Baretton, Gustavo, Krippendorf, Claudia, Bornhäuser, Martin, Ehninger, Gerhard, Folprecht, Gunnar, Thiede, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766716/
https://www.ncbi.nlm.nih.gov/pubmed/35069704
http://dx.doi.org/10.3389/fgene.2021.811291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766716/
https://www.ncbi.nlm.nih.gov/pubmed/35069704
http://dx.doi.org/10.3389/fgene.2021.811291

Ejemplares similares